308 related articles for article (PubMed ID: 20137091)
1. Evaluation of a community pharmacy-based intervention for improving patient adherence to antihypertensives: a randomised controlled trial.
Lau R; Stewart K; McNamara KP; Jackson SL; Hughes JD; Peterson GM; Bortoletto DA; McDowell J; Bailey MJ; Hsueh A; George J
BMC Health Serv Res; 2010 Feb; 10():34. PubMed ID: 20137091
[TBL] [Abstract][Full Text] [Related]
2. The (cost-)effectiveness of a patient-tailored intervention programme to enhance adherence to antihypertensive medication in community pharmacies: study protocol of a randomised controlled trial.
van der Laan DM; Elders PJ; Boons CC; Bosmans JE; Nijpels G; Hugtenburg JG
Trials; 2017 Jan; 18(1):29. PubMed ID: 28103948
[TBL] [Abstract][Full Text] [Related]
3. A multifaceted pharmacist intervention to improve antihypertensive adherence: a cluster-randomized, controlled trial (HAPPy trial).
Stewart K; George J; Mc Namara KP; Jackson SL; Peterson GM; Bereznicki LR; Gee PR; Hughes JD; Bailey MJ; Hsueh YA; McDowell JM; Bortoletto DA; Lau R
J Clin Pharm Ther; 2014 Oct; 39(5):527-34. PubMed ID: 24943987
[TBL] [Abstract][Full Text] [Related]
4. Determinants of community pharmacists' quality of care: a population-based cohort study using pharmacy administrative claims data.
Winslade N; Tamblyn R
BMJ Open; 2017 Sep; 7(9):e015877. PubMed ID: 28939571
[TBL] [Abstract][Full Text] [Related]
5. Impact of a community pharmacists' hypertension-care service on medication adherence. The AFenPA study.
Fikri-Benbrahim N; Faus MJ; Martínez-Martínez F; Sabater-Hernández D
Res Social Adm Pharm; 2013; 9(6):797-805. PubMed ID: 23391845
[TBL] [Abstract][Full Text] [Related]
6. Determinants of intentions to monitor antihypertensive medication adherence in Irish community pharmacy: a factorial survey.
Dillon P; McDowell R; Smith SM; Gallagher P; Cousins G
BMC Fam Pract; 2019 Sep; 20(1):131. PubMed ID: 31519171
[TBL] [Abstract][Full Text] [Related]
7. The effectiveness of daily SMS reminders in pharmaceutical care of older adults on improving patients' adherence to antihypertensive medication (SPPA): study protocol for a randomized controlled trial.
Haramiova Z; Stasko M; Hulin M; Tesar T; Kuzelova M; Morisky DM
Trials; 2017 Jul; 18(1):334. PubMed ID: 28720121
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of a medication adherence management intervention in a community pharmacy setting: a cluster randomised controlled trial.
Torres-Robles A; Benrimoj SI; Gastelurrutia MA; Martinez-Martinez F; Peiro T; Perez-Escamilla B; Rogers K; Valverde-Merino I; Varas-Doval R; Garcia-Cardenas V
BMJ Qual Saf; 2022 Feb; 31(2):105-115. PubMed ID: 33782092
[TBL] [Abstract][Full Text] [Related]
9. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial.
Lee JK; Grace KA; Taylor AJ
JAMA; 2006 Dec; 296(21):2563-71. PubMed ID: 17101639
[TBL] [Abstract][Full Text] [Related]
10. Community Pharmacists Assisting in Total Cardiovascular Health (CPATCH): A Cluster-Randomized, Controlled Trial Testing a Focused Adherence Strategy Involving Community Pharmacies.
Blackburn DF; Evans CD; Eurich DT; Mansell KD; Jorgenson DJ; Taylor JG; Semchuk WM; Shevchuk YM; Remillard AJ; Tran DA; Champagne AP
Pharmacotherapy; 2016 Oct; 36(10):1055-1064. PubMed ID: 27581815
[TBL] [Abstract][Full Text] [Related]
11. The Team Education and Adherence Monitoring (TEAM) trial: pharmacy interventions to improve hypertension control in blacks.
Svarstad BL; Kotchen JM; Shireman TI; Crawford SY; Palmer PA; Vivian EM; Brown RL
Circ Cardiovasc Qual Outcomes; 2009 May; 2(3):264-71. PubMed ID: 20031847
[TBL] [Abstract][Full Text] [Related]
12. Optimising the changing role of the community pharmacist: a randomised trial of the impact of audit and feedback.
Winslade N; Eguale T; Tamblyn R
BMJ Open; 2016 May; 6(5):e010865. PubMed ID: 27207626
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a Collaborative Protocolized Approach by Community Pharmacists and General Medical Practitioners for an Australian Minor Ailments Scheme: Protocol for a Cluster Randomized Controlled Trial.
Dineen-Griffin S; Garcia-Cardenas V; Rogers K; Williams K; Benrimoj SI
JMIR Res Protoc; 2019 Aug; 8(8):e13973. PubMed ID: 31400107
[TBL] [Abstract][Full Text] [Related]
14. Pharmacist intervention program to enhance hypertension control: a randomised controlled trial.
Morgado M; Rolo S; Castelo-Branco M
Int J Clin Pharm; 2011 Feb; 33(1):132-40. PubMed ID: 21365405
[TBL] [Abstract][Full Text] [Related]
15. Improving refill adherence and hypertension control in black patients: Wisconsin TEAM trial.
Svarstad BL; Kotchen JM; Shireman TI; Brown RL; Crawford SY; Mount JK; Palmer PA; Vivian EM; Wilson DA
J Am Pharm Assoc (2003); 2013; 53(5):520-9. PubMed ID: 24030130
[TBL] [Abstract][Full Text] [Related]
16. Targeted and tailored pharmacist-led intervention to improve adherence to antihypertensive drugs among patients with type 2 diabetes in Indonesia: study protocol of a cluster randomised controlled trial.
Alfian SD; Abdulah R; Denig P; van Boven JFM; Hak E
BMJ Open; 2020 Jan; 10(1):e034507. PubMed ID: 31911526
[TBL] [Abstract][Full Text] [Related]
17. Protocol for a randomised controlled trial evaluating the impact of a community pharmacy discharge medication reconciliation service on unplanned hospital readmissions - The DCMedsRec trial.
Duncan G; Ngo C; Fanning L; Taylor DA; McNamara K; Caliph S; Suen B; Johnston S; Darzins P
Res Social Adm Pharm; 2021 Feb; 17(2):460-465. PubMed ID: 32273252
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of Wisconsin TEAM model for improving adherence and hypertension control in black patients.
Shireman TI; Svarstad BL
J Am Pharm Assoc (2003); 2016; 56(4):389-96. PubMed ID: 27184784
[TBL] [Abstract][Full Text] [Related]
19. Bridging the gap between physical and mental illness in community pharmacy (
Wheeler AJ; O'Reilly CL; El-Den S; Byrnes J; Ware RS; McMillan SS
BMJ Open; 2020 Jul; 10(7):e039983. PubMed ID: 32709657
[TBL] [Abstract][Full Text] [Related]
20. Impact of Adherence Education and Monitoring on Community Pharmacy Performance Scores and Patient Satisfaction.
Sprouse C; Grant M; Remines J; Nadpara P; Goode JV
Innov Pharm; 2020; 11(3):. PubMed ID: 34007625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
